MIRA INFORM REPORT
|
Report Date : |
10.03.2011 |
IDENTIFICATION DETAILS
|
Correct Name : |
BIO PHARMA LTD |
|
|
|
|
Registered Office : |
1/12, Block-B Lalmatia, |
|
|
|
|
Country : |
|
|
|
|
|
Date of Incorporation : |
28.02.1999 |
|
|
|
|
Legal Form : |
Private Limited Company |
|
|
|
|
Line of Business : |
Manufacturing, Selling & Exporting of pharmaceutical products such
as Tablets, Capsules, Syrups, Suspensions, Ointments
& others dosage |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
US$ 35,000.00 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment
Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – December 31, 2010
|
Country Name |
Previous Rating (30.09.2010) |
Current Rating (31.12.2010) |
|
|
b1 |
b1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
COMPANY DETAILS
|
Name |
Bio Pharma Limited Note: The subject operates by this name. |
|
Address |
116/A,
BSCIC Area, Tongi, |
|
Country |
|
|
Telephone No |
880-2-8157953,
8150928, 8159481, 9801240 |
|
Fax No |
880-2-9134684 |
|
E-Mail |
|
|
Website |
|
|
Established |
1999 |
|
Company Registration No |
Cleared for
Registration |
|
Registration date |
28th
February 1999 |
|
Legal Status |
Private Limited |
|
Issuing Authority |
The Registrar of Joint Stock of Companies & Firms, |
|
Business Type |
Manufacturer, Seller & Exporter |
|
Status |
Satisfactory |
|
Payment Behavior |
No complaints have been heard regarding payments from local suppliers or banks. |
LOCATIONS
|
Head Office |
1/12,
Block-B Lalmatia, Dhaka- 1207, |
|
Telephone No |
880-2-8157953,
8150928, 8159481 |
|
Fax No |
880-2-9134684 |
|
E-Mail |
|
|
Website |
|
|
Branch |
4 4 Sylhet 4 Bogra 4 4 Rangpur 4 Barishal 4 Comilla 4 Cox’s Bazar 4 Jessore 4 Mymensing 4 Faridpur |
|
Factory |
116/A,
BSCIC Area, Tongi, |
|
Factory Fax No |
NIL |
|
Warehouse |
116/A, BSCIC
Area, Tongi, |
DIRECTORS
|
Name |
|
|
Designation |
Chairman &
Managing Director |
|
Nationality |
Bangladeshi |
|
|
|
|
Name |
Dr. Lokiat Ullah |
|
Designation |
Director |
|
Nationality |
Bangladeshi |
|
|
|
|
Name |
Mr. AA Khan |
|
Designation |
Director |
|
Nationality |
Bangladeshi |
SHAREHOLDERS
|
Name |
|
|
Designation |
50% |
|
Nationality |
Bangladeshi |
|
|
|
|
Name |
Dr. Lokiat Ullah |
|
Designation |
30% |
|
Nationality |
Bangladeshi |
|
|
|
|
Name |
Mr. AA Khan |
|
Designation |
20% |
|
Nationality |
Bangladeshi |
BUSINESS DETAILS
|
Line of Business |
Manufacturer,
Seller & Exporter |
|
Items Dealing In |
Pharmaceutical
Products |
|
Terms of Purchase |
Local: Cash or Credit Import: Against L/C |
|
Terms of |
Local: Cash or Credit Export: Against L/C / TT |
BANKERS
|
Name |
AL-Arafah Islami Bank Ltd |
|
Branch |
Corporate Branch |
|
Address |
125, Motijheel Commercial Area, Dhaka-1000 |
|
SWIFT |
N/A |
|
|
|
|
Name |
Islami Bank Bangladesh Limited |
|
Branch |
Dhanmondi Branch |
|
Address |
Nilu Squire, |
|
SWIFT |
N/A |
FINANCIAL INFORMATION
|
Year |
2009 |
2008 |
2007 |
|
Investment |
Tk.32 million |
Tk.32 million |
Tk.30 million |
|
Turnover |
Tk.392.6 million |
Tk.392 million |
Tk.391 million |
|
Liability |
Tk.1.9 million |
Tk.2.3 million |
Tk.3 million |
|
Assets |
Tk.48 million |
Tk.48 million |
Tk.45 million |
CAPITAL STRUCTURE
|
Authorized
Capital |
Tk.20 million |
|
Paid Up Capital |
Tk.250,000.00 |
|
Each Share Value |
Tk.100.00 |
EXCHANGE RATE
|
Currency |
Unit |
Bangladeshi Taka (BDT) |
|
|
1 |
115.6391 |
|
U.S Dollar |
1 |
71.5500 |
|
European Euro |
1 |
99.4903 |
ADVERSE DATA MONITORING
|
Dishonored
Checks |
No Found |
|
Debt |
No Records Found |
|
Litigation |
No Records Found |
|
Performance
Defaults |
No Records Found |
|
Adverse Press
Coverage |
No Records Found |
|
Money Laundering |
No Records Found |
MAXIMUM RECOMMENDED CREDIT
|
Amount |
Based On |
|
US$ 35,000.00 |
90 days |
GENERAL INFORMATION
|
Employees |
1,500 |
|
Office Area (Sq.
Ft) |
3,000 sq.ft (rented) |
|
Factory Area
(Sq. Ft) |
50,000 sq.ft (renteds) |
|
Warehouse Area
(Sq. Ft) |
8,000 sq.ft. (own) |
|
|
4 Antibiotics 4 Anti-Fungal-Drugs 4 Anti-Protozoal-Drugs 4 Anti-Histamines 4 Anti-Emetic 4 Anthelmintics 4 Antacid & Anti Ulcerants 4 Laxative Drug 4 Anti-Oxidant 4 Vitamins & Minerals 4 NSAIDs 4 Bronchodilators 4 Expectorants 4 Anti-Diabetic Drugs 4 Anti Depressants & Anxiolytics 4 Cardiovascular Drugs 4 Dermatological Products |
|
Raw Materials
From |
4 EEC Countries 4 4 |
|
Domestic Clients |
4 Local Specialized
Hospitals |
|
Export
Market |
4 4 4 4 4 4 4 4 4 |
|
Certifications |
NIL |
|
Group Name |
Impress Group |
|
Subsidiaries /
Affiliates |
4 Bio
Properties Ltd 4 Bio pharma
Agrovet Ltd 4 Bio Natures
Ltd 4 Bio Food
& Beverages Industries Ltd 4 Bio Health
Care Ltd 4 Biopharma
Foundation |
|
Member |
4 4 Dhaka Chamber of Commerce &
Industries, |
COMMENTS
The subject is a private limited company who is engaged in
manufacturing, selling & exporting of pharmaceutical products such as Tablets, Capsules, Syrups, Suspensions, Ointments & others
dosage. The subject was established as Bio Pharma Laboratories Ltd in
1990 and applied for name change from Bio Pharma Laboratories Ltd to Bio Pharma
Ltd in this year in The Registrar of Joint Stock Companies & Firms,
The directors are well conversant in their line of trade and they are
also experienced businessman. They are financially solvent and good at their
business commitments, it is reported.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.45.02 |
|
|
1 |
Rs.72.70 |
|
Euro |
1 |
Rs.62.54 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.